Chimerix (CMRX) Receives FDA Clearance for Rolling Submission of NDA for Brincidofovir as Medical Countermeasure for Smallpox

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Chimerix (CMRX) Receives FDA Clearance for Rolling Submission of NDA for Brincidofovir as Medical Countermeasure for Smallpox
CHIMERIX (NASDAQ: CMRX) Delayed: 8.54 --0 (-0%)
Previous Close $8.54    52 Week High $42.24 
Open $8.54    52 Week Low $3.50 
Day High $8.54    P/E N/A 
Day Low $8.54    EPS $-0.47 
Volume 82,600